Post-Transplantation Hairy Cell Leukemia with Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient: A Case of Rare Occurrence
DOI:
https://doi.org/10.61882/ijkd.19.04.8943Keywords:
Epstein-Barr virus infections, Hemophagocytic lymphohistiocytosis, Kidney transplantation, Hairy cell Leukemia, Transplant recipients, Lymphoproliferative disorders, Neoplasms, Immunosuppressive therapyAbstract
Post-transplant lymphoproliferative disorder (PTLD) is a rare and severe complication that occurs after kidney transplantation. Most cases of PTLD are associated with reactivation of the Epstein-Barr virus (EBV), which often happens during the early phases following transplantation. Hemophagocytic lymphohistiocytosis (HLH) is an inflammatory syndrome characterized by a cytokine storm originating from activation of the reticuloendothelial system, leading to multi-organ failure (MOF). Herein, we present a case of late-onset EBV-positive hairy cell leukemia in a kidney transplant recipient who concurrently developed HLH. Diagnosing and managing HLH can be particularly challenging, as it can mimic sepsis. This is especially true for transplant recipients, where diagnosing and treating such conditions are difficult. Immunosuppressive therapy, malignancies like lymphoma, and EBV infection are recognized risk factors for developing HLH. However, very few cases have reported the simultaneous occurrence of HLH and PTLD.
Downloads
References
1. Cho JM, Kim YC, Min S, Kim TM, Lee H. T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report. Korean J Transplant. 2023 Dec 31;37(4):299-305.
2. Mazzola Poli de Figueiredo S, Johnson JC, Lyapichev KA, Stevenson HL, Lea A, Hussain S, et al. Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient. Transplant Direct. 2022 Sep;8(9):e1368.
3. Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol. 1998 Jun;16(6):2052-9.
4. Allen U, Preiksaitis J. Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients. Am J Transplant. 2009 Dec;9 Suppl 4:S87-96.
5. Bakanay SM, Kaygusuz G, Topçuoğlu P, Sengül S, Tunçalı T, Keven K, et al. Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center. Turk J Haematol. 2014 Mar;31(1):79-83.
6. Troussard X, Maitre E. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment. J Cell Mol Med. 2024 Feb;28(3):e18060.
7. Robak T, Robak M, Majchrzak A, Krawczyńska A, Braun M. Atypical Hairy Cell Leukemia-The Current Status and Future Directions. Eur J Haematol. 2025 May;114(5):747-62.
8. Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017 Feb 2;129(5):553-60.
9. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004 Jan 27;77(2):238-43.
10. Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Rosée P, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia. 2024 Feb;38(2):235-49.
11. M D, P S, T P. Post-Transplant Lymphoproliferative Disorder as a Trigger for Hemophagocytic Lymphohistiocytosis in Solid Organ Transplant – Case Series [abstract]. American Transplant Congress: American Journal of Transplantation; 2021.
12. Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, et al. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. J Cancer Res Clin Oncol. 2020 Apr;146(4):1065-77.
13. Löfstedt A, Jädersten M, Meeths M, Henter JI. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival. Blood. 2024 Jan 18;143(3):233-42.
14. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860-1.
15. Bigenwald C, Fardet L, Coppo P, Meignin V, Lazure T, Fabiani B, et al. A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. Br J Haematol. 2018 Oct;183(1):68-75.
16. Marsh RA. Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis. Front Immunol. 2017;8:1902.
17. Zamfir A, Leymarie V, Galoisy A-C, Falkenrodt A, Epailly E, Fohrer C, et al. Successful Treatment af a Hairy Cell Leukemia (HCL) with Pentostatin in a Cardiac Transplant Recipient. Blood. 2004 2004/11/16/;104(11):4815.
